medigraphic.com
SPANISH

Acta Médica Grupo Angeles

Órgano Oficial del Hospital Angeles Health System
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
    • Names and affiliations of the Editorial Board
  • Policies
  • About us
    • Data sharing policy
    • Stated aims and scope
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2019, Number 3

<< Back Next >>

Acta Med 2019; 17 (3)

Fragile X syndrome

Navarro VG, Domínguez CLG
Full text How to cite this article

Language: Spanish
References: 13
Page: 259-262
PDF size: 144.40 Kb.


Key words:

Fragile X syndrome, intellectual disability, inherited mental retardation.

ABSTRACT

Introduction: Fragile X syndrome is an inherited disease linked to the X chromosome that mainly affects men and that causes principally intellectual disability; its etiology is a mutation by expansion of CGG trinucleotide repeats in the FMR1 gene located at region Xq27.3. Case report: Preschool of six years old with psychomotor delay, characterized by language and cognitive functions corresponding to two years of age; with phenotypic characteristics compatible with SXF, whose karyotype showed presence of mosaicism for 46, and fra (X) (q27.3), with associated problems of upper airways infection secondary to gastroesophageal reflux. Conclusions: Fragile X syndrome represents the most common cause of hereditary mental retardation, intellectual disability and autism, being the second most common cause of mental deficiencies genetically associated, after trisomy 21.


REFERENCES

  1. Martin JP, Bell J. A pedigree of mental defect showing sex-linkage. J Neurol Psychiatry. 1943; 6 (3-4): 154-157.

  2. Harris SW, Hessl D, Goodlin-Jones B, Ferranti J, Bacalman S, Barbato I et al. Autism profiles of males with fragile X syndrome. Am J Ment Retard. 2008; 113 (6): 427-438.

  3. Pieretti M, Zhang FP, Fu YH, Warren ST, Oostra BA, Caskey CT et al. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell. 1991; 66 (4): 817-822.

  4. Butler MG, Mangrum T, Gupta R, Singh DN. A 15-item checklist for screening mentally retarded males for the fragile X syndrome. Clin Genet. 1991; 39 (5): 347-354.

  5. Hall SS, Dougherty RF, Reiss AL. Profiles of aberrant white matter microstructure in fragile X syndrome. Neuroimage Clin. 2016; 11: 133-138.

  6. Kidd SA, Lachiewicz A, Barbouth D, Blitz RK, Delahunty C, McBrien D et al. Fragile X syndrome: a review of associated medical problems. Pediatrics. 2014; 134 (5): 995-1005.

  7. Oviedo N, Manuel-Apolinar L, de la Chesnaye E, Guerra-Araiza C. Aspectos genéticos y neuroendocrinos en el trastorno del espectro autista. Bol Med Hosp Infant Mex. 2015; 72 (1): 5-14.

  8. Del Hoyo-Soriano L, Thurman AJ, Harvey DJ, Ted Brown W, Abbeduto L. Genetic and maternal predictors of cognitive and behavioral trajectories in females with fragile X syndrome. J Neurodev Disord. 2018; 10 (1): 22.

  9. Alliende RMA, Aravena CT, Valiente GA, Curotto LB, Santa María VL, Cortés MF. Tamizaje clínico y análisis de mutaciones en el gen FMR1 en 99 varones con características clínicas del síndrome de X-frágil. Rev Chil Pediatr. 2006; 77 (1): 34-42.

  10. Rifé-Soler M, Sánchez-Díaz A, Ramos F, Mila-Recasens M. Estudio de la proteína FMRP en la raíz de cabello: aplicación al diagnóstico del síndrome del cromosoma X frágil. An Pediatr. 2003; 59 (5): 431-435.

  11. Abrams L, Cronister A, Brown WT, Tassone F, Sherman SL, Finucane B et al. Newborn, carrier, and early childhood screening recommendations for fragile X. Pediatrics. 2012; 130 (6): 1126-1135.

  12. Hersh JH, Saul RA; Committee on Genetics. Health supervision for children with fragile X syndrome. Pediatrics. 2011; 127 (5): 994-1006.

  13. Leigh MJ, Nguyen DV, Mu Y, Winarni TI, Schneider A, Chechi T et al. A randomized double-blind, placebo-controlled trial of minocycline in children and adolescents with fragile x syndrome. J Dev Behav Pediatr. 2013; 34 (3): 147-155.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Acta Med. 2019;17